DXS Track One

Date: Thursday, 13 October 2016
Location: Singapore

Guest of Honour

Lim Chuan Poh
Chairman, A*STAR

Plenary Speakers

Jean-Luc Butel
Global Healthcare Advisor, President, K8 Global & Senior Advisor , McKinsey&Company

Fred Kramer
Professor, New Jersey Medical School Rutgers University

Chwee Teck Lim
NUS Society Chair Professor, Department of Biomedical Engineering, Institute for Health Innovation & Technology (iHealthtech), Mechanobiology Institute, National University of Singapore

Rudi Pauwels
Founder Director/Chief Executive Officer, Biocartis

Keynote Speakers

Shian-Jiun Shih
Partner, Kiang Consulting Services

Timothy Barkham
Doctor, Tan Tock Seng Hospital

Richard Simpson
Professor, La Trobe University

Mike Makrigiorgos
Professor and Director of Medical Physics and Biophysics, Harvard Medical School

Overview

Select Bio and the Diagnostics Development Hub, part of Exploit Technologies Pte. Ltd. present Singapore’s inaugural Diagnostics Summit.

The event will take place on the 13-14 October at the Biopolis, Singapore’s custom built biomedical research and development hub, home to a large number of the world’s leading Life Science organisations and A*STAR research institutes.

Bringing together industry professionals, entrepreneurs, researchers, academia and students, this comprehensive two day meeting will look to address the challenges of translating the latest advances in scientific research into tangible diagnostics solutions.

The focus for this conference track is to present the latest research and commercial activities within the field of Circulating Biomarkers. We will examine the various characterization of these classes of biomarkers especially as circulating biomarkers for cancer and other disease classes.

Please see below for a comprehensive list of the subject areas to be addressed.

Agenda Topics

Circulating DNA, Circulating RNA, Circulating Tumor Cells, Circulating Proteins

Circulating Biomarker Classes: Exosomes, Microvesicles, Circulating-Free DNA (cfDNA), Circulating RNA, Circulating Tumor Cells
Circulating microRNAs
Circulating Protein Biomarkers
Circulating Transcriptome
Circulating-Free (cfDNA) in various Cancer Classes
Circulating-Free DNA
Next-Generation Sequencing (NGS), Digital PCR and qPCR Development for analysis of cf-DNA

Exosomes and Microvesicles

Extracellular Vesicle-based Biomarkers: Exosomes and Microvesicles in Biological Fluids
Extracellular Vesicles as Biomarker Carriers in Various Disease Classes
Research Methodologies and Workflow: Isolation, Capture, Biomarker Cargo Analysis
Various Subclasses of Extracellular Vesicles (EVs) and their Biomarker Cargo: Exosomes, Microvesicles, Oncosomes

Sponsorship and Exhibition Opportunities

Paul Raggett, Exhibition Manager
p.raggett@selectbio.com
+855 6999 5137

Confirmed Speakers to date

Kuo Ping Chiu, Associate Research Fellow, Genomics Research Centre, Academia Sinica
Isaac Garcia-Murillas, Senior Scientific Officer, Institute Of Cancer Research
Sai Kiang Lim, Research Director, Institute of Medical Biology, A*STAR
Dobrin Nedelkov, Research Scientist, Arizona State University
Juergen Schaefer, Mass Spectrometry Lab Head, Sanofi
Valérie Taly, CNRS Research Director, Professor and Group leader Translational Research and Microfluidics, Université Paris Cité
Heng-Phon Too, Associate Professor, National University of Singapore
Jay West, Senior Director of R&D, Fluidigm Corporation
William G Whitford, Life Science Strategic Solutions Leader, DPS Group
Andrea Wijeweera, Sales Application Specialist, QIAGEN